Oxycodone (Oxycodone Amneal) 5 mg tablets: Supply issue
Due to shipping delays, there is a supply issue affecting the 5 mg immediate release oxycodone tablets.
Affected product
Due to shipping delays, there is a supply issue affecting:
- Chemical: Oxycodone hydrochloride
- Presentation: Tab immediate-release 5 mg
- Brand: Oxycodone Amneal
- Pharmacode: 2681919 and 2696053
- Subsidy: $13.77
- Measure / Qty: per 100
Schedule listing for oxycodone(external link)
Unaffected products
Currently, there are no concerns for the other strengths, oral liquid, or the controlled-release capsules.
Alternative product
The 10 mg immediate release tablet has a score line and the Datasheet indicates that the tablet can be halved. The oral liquid (1 mg / ml) is also available. Rule 3.4.2 applies for funding, however a new prescription may be needed to meet requirements of the Misuse of Drugs Regulations.
Prescribers may also want to consider prescribing an alternative analgesic.
We acknowledge that this will cause create disruption for those affected. We have developed a flyer to support conversations with people affected by this supply issue.
- Flyer: Oxycodone IR 5 mg supply issue (Mar 25) [PDF 56 KB]
Expected resupply
The next shipment is due in mid-to-late March 2025. It will take another 1 to 2 weeks to reach pharmacies around the motu.
Who to contact
If you have questions about this issue, email enquiry@pharmac.govt.nz
Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.
Sign up to our email list for regular emails about supply issues and more(external link)